Evernest Financial Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.58M Buy
10,172
+112
+1% +$26.1K 0.54% 33
2026
Q1
$2.27M Buy
10,060
+440
+5% +$102K 0.47% 35
2025
Q4
$2.3M Buy
9,620
+637
+7% +$126K 0.48% 36
2025
Q3
$1.67M Sell
8,983
-85
-0.9% -$14.6K 0.47% 43
2025
Q2
$1.39M Buy
9,068
+44
+0.5% +$6.76K 0.45% 46
2025
Q1
$1.5M Buy
9,024
+1,163
+15% +$182K 0.54% 35
2024
Q4
$1.14M Buy
7,861
+280
+4% +$43.4K 0.29% 60
2024
Q3
$1.23M Sell
7,581
-251
-3% -$40K 0.33% 52
2024
Q2
$1.14M Sell
7,832
-913
-10% -$136K 0.51% 42
2024
Q1
$1.29M Sell
8,745
-1,183
-12% -$188K 0.61% 33
2023
Q4
$1.56M Buy
+9,928
New +$1.52M 0.79% 30
2021
Q4
$1.39M Buy
+8,839
New +$1.45M 0.72% 30

Other funds holding JNJ

Evernest Financial Advisors's JNJ Position: Q2 2026 in Review

Evernest Financial Advisors increased its Johnson & Johnson (JNJ) stake by 1.1% in Q2 2026, buying an estimated $26.1K and bringing the position to 10,172 shares worth $2.58M. The position accounts for 0.54% of the portfolio, ranked #33.

Evernest Financial Advisors first reported a position in JNJ in Q4 2021 and has held it in 12 quarters since. 4,691 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Evernest Financial Advisors held 10,172 shares of Johnson & Johnson worth $2.58M as of Q2 2026.
  • Evernest Financial Advisors bought 112 Johnson & Johnson shares in Q2 2026, an estimated $26.1K.
  • Johnson & Johnson made up 0.54% of Evernest Financial Advisors's portfolio in Q2 2026, its #33 holding.
  • Evernest Financial Advisors first reported a position in Johnson & Johnson in Q4 2021 and has held it in 12 quarters since.
  • 4,691 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Evernest Financial Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.